Dr. Mark Holterman works for the University of Illinois College of Medicine as a professor teaching students about pediatrics and surgery. His experience in the healthcare field has also led to him being on the board of a number of organizations in his industry. Dr. Mark Holterman is also an entrepreneur, having co-founded the Alliance for the Advancement of Cellular Therapies (AACT) (Twitter). He serves on this organizations board as well, which is an organization that formed a partnership with CellR4, a peer-reviewed medical journal, that disseminates the studies that researchers present at the conferences that AACT holds.
Another organization that Dr. Mark Holterman provides his expertise to is the American Diabetes Association. He was once honored by this organization with their prestigious Innovative Research Award. This award is given to those who do significant research into the causes and potential cures for diabetes. Furthermore, the American Diabetes Association provides financial support to research initiatives into this disease. The award they presented to Dr. Mark Holterman is generally given to those who are engaged in either early-age studies or are on the brink of releasing a major research paper.
Dr. Mark Holterman is a graduate of Yale University, having earned his BA in Biology there in 1980. He then attended the University of Virginia where he graduated in 1988 with his MD-PhD in medicine and immunology. He served his residency in general surgery at the University of Virginia and his fellowship in pediatric surgery at Seattle Children’s Hospital.
Over the course of his career, Dr. Mark Holterman has taught at a number of universities. This includes the University of Illinois at Chicago and the University of Illinois College of Medicine-Peoria (https://health.usnews.com/doctors/mark-holterman-3618). He has also worked as a pediatric surgeon himself. This includes performing his work at Rush University Medical Center, as an attending pediatric surgeon, and at OSF Healthcare in the same position. He founded his first company, Mariam Global Health, in 2012 and continues to serve as its chief executive officer. At this company, he focuses on investing in healthcare companies around the world. The particular emphasis is on business ventures headed up by innovative managers.